Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9130
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLin, Ting-Sheng-
dc.contributor.authorLee, Jyh-Hong-
dc.contributor.authorWang, Li-Chieh-
dc.contributor.authorYang, Yao-Hsu-
dc.contributor.authorLau, Yu-Lung-
dc.contributor.authorLee, Wen-I-
dc.date.accessioned2024-12-17T02:41:46Z-
dc.date.available2024-12-17T02:41:46Z-
dc.date.issued2023-02-
dc.identifier.citationOriginal Articleen_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9130-
dc.description.abstractAbstract Background: Chronic granulomatous disease (CGD) is a rare primary immunodeficiency disease characterized by defective neutrophil killing of microbial pathogens and recurrent infections. We aimed to investigate the clinical, genetic features, treatment, and outcomes in patients with CGD. Methods: Pediatric patients diagnosed with CGD from a medical center in Taiwan were enrolled from January 1999 to Oct 2021. Results: Nine pediatric patients with CGD were enrolled: six X-linked (XL) CGD with CYBB gene mutations, three autosomal recessive (AR) CGD with two NCF1 and one CYBA gene mutations. The median age of onset and age of diagnosis was 0.92 and 2.64 years, respectively. Patients with XL-CGD had a younger age of onset (4.6 months vs. 1.83 years, P Z 0.06) and age of diagnosis (1.71 vs. 8.86 years, P Z 0.024) than AR-CGD patients. The most common sites of infections were skin and soft tissue abscesses. The most common pathogens were Staphylococcus, Serratia, and Salmonella spp. Prophylactic antibiotics, anti-fungal agents, and interferon-gamma (IFN-g) were given in 9 (100%), 7 (77.8%), and 8 (88.9%) patients, respectively. The mean duration of IFN-g usage was 5.15 years. One male patient with XL-CGD was successfully treated with hematopoietic stem cell transplantation at 2.2 years. The mortality rate was 11.1%, and the estimated overall survival at 20 years was 66.7%. Conclusion: Staphylococcus aureus, Serratia marcescens, and Salmonella infections are important in Taiwanese CGD patients. Patients with XL-CGD have early disease onset. IFNg prophylaxis and prophylactic anti-microbial agents might have an effect on alleviating the infection episodes in CGD patients.en_US
dc.language.isoen_USen_US
dc.publisherJournal of Microbiologi, Immunology and Infectionen_US
dc.subjectChronic granulomatous diseaseen_US
dc.subjectHematopoietic stem cell transplantationen_US
dc.subjectInterferon-gammaen_US
dc.subjectPrimary immunodeficienciesen_US
dc.titleClinical features and outcomes of patients with chronic granulomatous disease in Taiwanen_US
dc.typeArticleen_US
Appears in Collections:VOL 56 NO 1 2023

Files in This Item:
File Description SizeFormat 
130-138.pdf877.06 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.